Cidara Therapeutics (NASDAQ: CDTX) reported Q1 EPS of ($2.28), $2.21 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.46 million versus the consensus estimate of $13.05 million.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.